Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Andersen

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|May 4, 2005
Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfectionCamilla S Graham, Annalee Wells, Tun Liu, et al.
AIDS (London, England)|January 28, 2006
Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infectionCamilla S Graham, Annalee Wells, Tun Liu, et al.
The Journal of Infectious Diseases|September 23, 2006
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group studyDavid W Haas, Daniel E Geraghty, Janet Andersen, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084Jane Hitti, Janet Andersen, Grace McComsey, et al.
Plos One|July 10, 2010
Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infectionPhilip M Grant, Lauren Komarow, Janet Andersen, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 5, 2007
Viral factors associated with cytokine expression during HCV/HIV co-infectionJason T Blackard, Minhee Kang, J Benjamin St Clair, et al.
AIDS Patient Care and Stds|August 23, 2007
Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive studyWilliam D King, Donna Defreitas, Kimberly Smith, et al.
The Journal of Infectious Diseases|September 25, 2012
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164Philip M Grant, Lauren Komarow, Michael M Lederman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039Keith Chirgwin, Richard Hafner, Catherine Leport, et al.
AIDS (London, England)|September 10, 2002
A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDSChristina M Marra, Natasa Rajicic, David E Barker, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|May 4, 2005
Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfectionCamilla S Graham, Annalee Wells, Tun Liu, et al.
AIDS (London, England)|January 28, 2006
Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infectionCamilla S Graham, Annalee Wells, Tun Liu, et al.
The Journal of Infectious Diseases|September 23, 2006
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group studyDavid W Haas, Daniel E Geraghty, Janet Andersen, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084Jane Hitti, Janet Andersen, Grace McComsey, et al.
Plos One|July 10, 2010
Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infectionPhilip M Grant, Lauren Komarow, Janet Andersen, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 5, 2007
Viral factors associated with cytokine expression during HCV/HIV co-infectionJason T Blackard, Minhee Kang, J Benjamin St Clair, et al.
AIDS Patient Care and Stds|August 23, 2007
Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive studyWilliam D King, Donna Defreitas, Kimberly Smith, et al.
The Journal of Infectious Diseases|September 25, 2012
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164Philip M Grant, Lauren Komarow, Michael M Lederman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039Keith Chirgwin, Richard Hafner, Catherine Leport, et al.
AIDS (London, England)|September 10, 2002
A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDSChristina M Marra, Natasa Rajicic, David E Barker, et al.
Pageof 3